RGEN
NASDAQStockRepligen Corporation
$114.62-4.78 (-4.01%)
52-Week Range
$108.89
$172.26
Key Stats
Market Cap
6.5B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.18
Volume
910.9K
Avg Volume
859.2K
Performance
1M
-16.66%
3M
-24.25%
6M
+4.83%
YTD
-27.45%
1Y
-17.98%
3Y
-29.49%
5Y
-41.56%
Price Chart
ETF Exposure
RGEN is held by 159 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| FRTY | Alger Mid Cap 40 ETF | 3.50% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 2.61% |
| PBE | Invesco Biotechnology & Genome ETF | 2.59% |
| CSMD | Congress SMID Growth ETF | 1.94% |
| SMAP | Amplify Small-Mid Cap Equity ETF | 1.45% |
| FXH | First Trust Health Care AlphaDEX Fund | 1.36% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 1.23% |
| SGRW | Harbor Active Small Cap Growth ETF (SGRW) | 1.16% |
| HELX | Franklin Genomic Advancements ETF | 1.05% |
| BBH | VanEck Biotech ETF | 0.95% |
| GSC | Goldman Sachs Small Cap Equity ETF | 0.83% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.79% |
| WDNA | WisdomTree BioRevolution Fund | 0.75% |
| FMED | FIDELITY DISRUPTIVE MEDICINE ETF | 0.70% |
| IQSM | NYLI Candriam U.S. Mid Cap Equity ETF | 0.61% |
| IBB | iShares Biotechnology ETF | 0.56% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.55% |
| PAMC | Pacer Lunt MidCap Multi-Factor Alternator ETF | 0.55% |
| ATFV | Alger 35 ETF | 0.53% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.43% |
| DMRM | DeltaShares S&P 400 Managed Risk ETF | 0.40% |
| SIXL | ETC 6 Meridian Low Beta Equity ETF | 0.34% |
| MIDE | Xtrackers S&P MidCap 400 Scored & Screened ETF | 0.31% |
| JHSC | John Hancock Investments - Multifactor Small Cap ETF | 0.28% |
| ETHO | Amplify Etho Climate Leadership U.S. ETF | 0.26% |
| PTMC | Pacer Trendpilot US Mid Cap ETF | 0.25% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 0.25% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.25% |
| VBK | Vanguard Small-Cap Growth ETF | 0.25% |
| SPIN | State Street US Equity Premium Income ETF | 0.24% |
| IVOO | Vanguard S&P Mid-Cap 400 ETF | 0.23% |
| QVMM | Invesco S&P MidCap 400 QVM Multi-factor ETF | 0.23% |
| XJH | iShares ESG Select Screened S&P Mid-Cap ETF | 0.22% |
| IVOV | Vanguard S&P Mid-Cap 400 Value ETF | 0.22% |
| SFYX | SoFi Next 500 ETF | 0.22% |
| FNX | First Trust Mid Cap Core AlphaDEX Fund | 0.21% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.21% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 0.20% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 0.20% |
| SPMD | State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.20% |
| IJH | iShares Core S&P Mid-Cap ETF | 0.19% |
| MDY | State Street SPDR S&P MIDCAP 400 ETF Trust | 0.19% |
| MDYV | State Street SPDR S&P 400 Mid Cap Value ETF | 0.18% |
| IJJ | iShares S&P Mid-Cap 400 Value ETF | 0.18% |
| FSMD | FIDELITY SMALL-MID MULTIFACTOR ETF | 0.18% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 0.17% |
| STXM | Strive Mid-Cap ETF | 0.16% |
| MVV | ProShares - Ultra MidCap400 | 0.15% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.15% |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | 0.14% |
Page 1 of 4Next
About RGEN ETF Exposure
Repligen Corporation (RGEN) is held by 159 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 6.5B, RGEN is a widely held institutional stock. The stock currently trades at $114.62. Investors can gain exposure to RGEN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RGEN, sorted by portfolio weight.